Publisher Correction: Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly (Scientific Reports, (2018), 8, 1, (8548), 10.1038/s41598-018-26944-x);Mitochondrial function is impaired in the skeletal muscle of pre-frail elderly

Scientific Reports

Volumn 8, Issue 1, 2018, Pages

  Andreux, Pénélope A ^a   Van Diemen, Marcus P J ^a   Heezen, Maxime R ^a   Auwerx, Johan ^a   Rinsch, Chris ^a   Jan Groeneveld, Geert ^a   Singh, Anurag ^a  

^a EPFL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; AGING; CASE CONTROL STUDY; CLINICAL TRIAL; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MUSCLE MITOCHONDRION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; SARCOPENIA; SKELETAL MUSCLE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AGING; BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; SARCOPENIA;

EID: 85048138312     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-019-54822-7     Document Type: Erratum

References (61)

1. Fernandez-Garrido, J., Ruiz-Ros, V., Buigues, C., Navarro-Martinez, R. & Cauli, O. Clinical features of prefrail older individuals and emerging peripheral biomarkers: a systematic review. Archives of gerontology and geriatrics 59, 7-17 (2014).
2. Manton, K. G. & Gu, X. Changes in the prevalence of chronic disability in the United States black and nonblack population above age 65 from 1982 to 1999. Proceedings of the National Academy of Sciences of the United States of America 98, 6354-6359, (2001).
3. Fried, L. P. et al. Frailty in older adults: evidence for a phenotype. The journals of gerontology. Series A, Biological sciences and medical sciences 56, M146-156 (2001).
4. Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and ageing 39, 412-423 (2010).
5. Werner, C. (ed. Economics and Statistics Administration U.S. Department of Commerce) (2011).
6. Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194-1217 (2013).
7. Green, D. R., Galluzzi, L. & Kroemer, G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109-1112 (2011).
8. Houtkooper, R. H., Williams, R. W. & Auwerx, J. Metabolic networks of longevity. Cell 142, 9-14 (2010).
9. Kauppila, T. E. S., Kauppila, J. H. K. & Larsson, N. G. Mammalian Mitochondria and Aging: An Update. Cell Metab 25, 57-71 (2017).
10. Short, K. R. et al. Decline in skeletal muscle mitochondrial function with aging in humans. Proceedings of the National Academy of Sciences of the United States of America 102, 5618-5623 (2005).
11. Broskey, N. T. et al. Exercise efficiency relates with mitochondrial content and function in older adults. Physiological reports 3, (2015).
12. Marzetti, E. et al. Association between myocyte quality control signaling and sarcopenia in old hip-fractured patients: Results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study. Experimental gerontology 80, 1-5 (2016).
13. Waters, D. L. et al. Mitochondrial function in physically active elders with sarcopenia. Mechanisms of ageing and development 130, 315-319 (2009).
14. Santanasto, A. J. et al. Skeletal Muscle Mitochondrial Function and Fatigability in Older Adults. The journals of gerontology. Series A, Biological sciences and medical sciences 70, 1379-1385 (2015).
15. Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545-15550 (2005).
16. Coen, P. M. et al. Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults. The journals of gerontology. Series A, Biological sciences and medical sciences 68, 447-455 (2013).
17. Broskey, N. T. et al. Skeletal muscle mitochondria in the elderly: effects of physical fitness and exercise training. J Clin Endocrinol Metab 99, 1852-1861 (2014).
18. Zane, A. C. et al. Muscle strength mediates the relationship between mitochondrial energetics and walking performance. Aging cell 16, 461-468 (2017).
19. Joseph, A. M. et al. The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary highand low-functioning elderly individuals. Aging cell 11, 801-809 (2012).
20. Radom-Aizik, S. et al. Effects of aerobic training on gene expression in skeletal muscle of elderly men. Medicine and science in sports and exercise 37, 1680-1696 (2005).
21. Melov, S., Tarnopolsky, M. A., Beckman, K., Felkey, K. & Hubbard, A. Resistance exercise reverses aging in human skeletal muscle. PloS one 2, e465 (2007).
22. Leick, L. et al. Endurance exercise induces mRNA expression of oxidative enzymes in human skeletal muscle late in recovery. Scand J Med Sci Sports 20, 593-599 (2010).
23. Pilegaard, H., Ordway, G. A., Saltin, B. & Neufer, P. D. Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279, E806-814 (2000).
24. Schmitt, B. et al. Transcriptional adaptations of lipid metabolism in tibialis anterior muscle of endurance-trained athletes. Physiol Genomics 15, 148-157 (2003).
25. Lammers, G. et al. Expression of genes involved in fatty acid transport and insulin signaling is altered by physical inactivity and exercise training in human skeletal muscle. Am J Physiol Endocrinol Metab 303, E1245-1251 (2012).
26. Dalton, J. T. et al. The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial. J Cachexia Sarcopenia Muscle 2, 153-161 (2011).
27. Papanicolaou, D. A. et al. A phase IIA randomized, placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator (SARM), MK-0773 in female participants with sarcopenia. The journal of nutrition, health & aging 17, 533-543 (2013).
28. Storer, T. W. et al. Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. J Clin Endocrinol Metab 102, 583-593 (2017).
29. Rooks, D. et al. Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof-of-Concept Study. J Am Geriatr Soc 65, 1988-1995 (2017).
30. Yanai, H. Nutrition for Sarcopenia. Journal of Clinical Medicine Research 7, 926-931 (2015).
31. Evans, M. et al. Efficacy of a novel formulation of L-Carnitine, creatine, and leucine on lean body mass and functional muscle strength in healthy older adults: a randomized, double-blind placebo-controlled study. Nutr Metab (Lond) 14, 7 (2017).
32. Badrasawi, M., Shahar, S., Zahara, A. M., Nor Fadilah, R. & Singh, D. K. Efficacy of L-carnitine supplementation on frailty status and its biomarkers, nutritional status, and physical and cognitive function among prefrail older adults: a double-blind, randomized, placebo-controlled clinical trial. Clin Interv Aging 11, 1675-1686 (2016).
33. Gimenes, A. C. et al. Effect of L-carnitine on exercise performance in patients with mitochondrial myopathy. Braz J Med Biol Res 48, 354-362 (2015).
34. Ramirez-Sanchez, I. et al. (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. Int J Cardiol 168, 3982-3990 (2013).
35. Ryu, D. et al. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Sci Transl Med 8, 361ra139 (2016).
36. Canto, C. et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity. Cell Metab 15, 838-847 (2012).
37. Gong, B. et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-gamma coactivator 1alpha regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging 34, 1581-1588 (2013).
38. Khan, N. A. et al. Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3. EMBO Mol Med 6, 721-731 (2014).
39. Tomas-Barberan, F. A. et al. Urolithins, the rescue of "old" metabolites to understand a "new" concept: Metabotypes as a nexus among phenolic metabolism, microbiota dysbiosis, and host health status. Mol Nutr Food Res 61 (2017).
40. Ryu, D. et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat Med 22, 879-888 (2016).
41. Marzetti, E. et al. Role of mitochondrial dysfunction and altered autophagy in cardiovascular aging and disease: from mechanisms to therapeutics. American journal of physiology. Heart and circulatory physiology 305, H459-476 (2013).
42. Craig, C. L. et al. International physical activity questionnaire: 12-country reliability and validity. Medicine and science in sports and exercise 35, 1381-1395 (2003).
43. Janssen, I., Heymsfield, S. B., Baumgartner, R. N. & Ross, R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. Journal of applied physiology (Bethesda, Md.: 1985) 89, 465-471 (2000).
44. Steihaug, O. M., Gjesdal, C. G., Bogen, B. & Ranhoff, A. H. Identifying Low Muscle Mass in Patients with Hip Fracture: Validation of Biolectrical Impedance Analysis and Anthropometry Compared to Dual Energy X-ray Absorptiometry. The journal of nutrition, health & aging 20, 685-690 (2016).
45. Pietilainen, K. H. et al. Agreement of bioelectrical impedance with dual-energy X-ray absorptiometry and MRI to estimate changes in body fat, skeletal muscle and visceral fat during a 12-month weight loss intervention. The British journal of nutrition 109, 1910-1916 (2013).
46. Guralnik, J. M. et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. Journal of gerontology 49, M85-94 (1994).
47. Guralnik, J. M. et al. Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery. The journals of gerontology. Series A, Biological sciences and medical sciences 55, M221-231 (2000).
48. Mentiplay, B. F. et al. Assessment of Lower Limb Muscle Strength and Power Using Hand-Held and Fixed Dynamometry: A Reliability and Validity Study. PloS one 10, e0140822 (2015).
49. Whiteley, R. et al. Correlation of isokinetic and novel hand-held dynamometry measures of knee flexion and extension strength testing. Journal of science and medicine in sport 15, 444-450 (2012).
50. Koblbauer, I. F. et al. Reliability of maximal isometric knee strength testing with modified hand-held dynamometry in patients awaiting total knee arthroplasty: useful in research and individual patient settings? A reliability study. BMC musculoskeletal disorders 12, 249 (2011).
51. Wright, B. M. A simple mechanical ataxia-meter. The Journal of physiology 218(Suppl), 27p-28p (1971).
52. Wu, J. S., Buettner, C., Smithline, H., Ngo, L. H. & Greenman, R. L. Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications. Muscle & nerve 43, 76-81 (2011).
53. Pipinos, I. I., Shepard, A. D., Anagnostopoulos, P. V., Katsamouris, A. & Boska, M. D. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle. Journal of vascular surgery 31, 944-952 (2000).
54. Nachbauer, W. et al. Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin. PloS one 8, e69229 (2013).
55. Di Marzo, L. et al. 31Phosphorus magnetic resonance spectroscopy to evaluate medical therapy efficacy in peripheral arterial disease. A pilot study. Panminerva medica 41, 283-290 (1999).
56. van den Broek, N. M., De Feyter, H. M., de Graaf, L., Nicolay, K. & Prompers, J. J. Intersubject differences in the effect of acidosis on phosphocreatine recovery kinetics in muscle after exercise are due to differences in proton efflux rates. American journal of physiology. Cell physiology 293, C228-237 (2007).
57. Lanza, I. R., Bhagra, S., Nair, K. S. & Port, J. D. Measurement of human skeletal muscle oxidative capacity by 31P-MR spectroscopy: a cross-validation with in vitro measurements. Journal of magnetic resonance imaging: JMRI 34, 1143-1150 (2011).
58. Tarnopolsky, M. A., Pearce, E., Smith, K. & Lach, B. Suction-modified Bergstrom muscle biopsy technique: experience with 13, 500 procedures. Muscle & nerve 43, 717-725 (2011).
59. Spendiff, S. et al. Mitochondrial DNA deletions in muscle satellite cells: implications for therapies. Human molecular genetics 22, 4739-4747 (2013).
60. Team, R. C. R. A Language and Environment for Statistical Computing, https://www.r-project.org/ (2015).
61. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).